MED-SURG II HESI EXAM NEWEST ACTUAL EXAM 2025/2026
WITH COMPLETE 100 QUESTIONS AND CORRECT DETAILED
ANSWERS (VERIFIED ANSWERS) WITH RATIONALES |ALREADY
GRADED A+
The nurse is evaluating a client with hyperthyroidism who is taking
Propylthiouracil (PTU) 100 mg/day in three divided doses for maintenance
therapy. Which of the following statements from the client indicates the desired
outcome of the
drug?
1. "I have excess energy throughout the day."
2. "I am able to sleep and rest at night."
3. "I have lost weight since taking this medication."
4. "I do perspire throughout the entire day."
2. "I am able to sleep and rest at night."
PTU is a prototype of thioamide antithyroid drugs. It inhibits production of thyroid
hormones and peripheral conversion of T4 to the more active T3. A client taking
this antithyroid drug should be able to sleep and rest well at night since the level
of thyroid hormones is reduced in the blood. Excess energy throughout the day,
loss of weight and perspiring through the day are symptoms of hyperthyroidism
indicating the drug has not produced its outcome.
CN: Pharmacological and parenteral therapies; CL: Evaluate.
The nurse should teach the client with Graves' disease to prevent corneal
irritation from mild exophthalmos by:
1. Massaging the eyes at regular intervals.
2. Instilling an ophthalmic anesthetic as prescribed.
1|Page
, Med-Surg II HESI Exam
3. Wearing dark-colored glasses.
4. Covering both eyes with moistened gauze pads.
3. Wearing dark-colored glasses.
Treatment of mild ophthalmopathy that may accompany thyrotoxicosis includes
measures such as wearing sunglasses to protect the eyes from corneal irritation.
Treatment of ophthalmopathy should be performed in consultation with an
ophthalmologist. Massaging the eyes will not help to protect the cornea. An
ophthalmic
anesthetic is used to examine and possibly treat a painful eye, not protect the
cornea. Covering the eyes with moist gauze pads is not a satisfactory nursing
measure to protect
the eyes of a client with exophthalmos because treatment is not focused on
moisture to the eye but rather on protecting the cornea and optic nerve. In
exophthalmos, the retrobulbar connective tissues and extraocular muscle volume
are expanded because of fluid retention. The pressure is also increased.
CN: Reduction of risk potential; CL: Synthesize
A client with Graves' disease is treated with radioactive iodine (RAI) in the
form of sodium iodide 131I. Which of the following statements by the nurse will
explain to the client how the drug works?
1. "The RAI stabilizes the thyroid hormone levels before a thyroidectomy."
2. "The RAI reduces uptake of thyroxine and thereby improves your condition."
3. "The RAI lowers the levels of thyroid hormones by slowing your body's
production of them."
4. "The RAI destroys thyroid tissue so that thyroid hormones are no longer
produced."
4. "The RAI destroys thyroid tissue so that thyroid hormones are no longer
produced."
2|Page
, Med-Surg II HESI Exam
Sodium iodide 131I destroys the thyroid follicular cells, and thyroid hormones are
no longer produced. RAI is commonly recommended for clients with Graves'
disease, especially the elderly. The treatment results in a "medical
thyroidectomy." RAI is given in lieu of surgery, not before surgery. RAI does not
reduce uptake of thyroxine.
The outcome of giving RAI is the destruction of the thyroid follicular cells. It is
possible to slow the production of thyroid hormones with RAI.
CN: Pharmacological and parenteral therapies; CL: Synthesize
After treatment with radioactive iodine (RAI) in the form of sodium iodide 131I,
the nurse teaches the client to:
1. Monitor for signs and symptoms of hyperthyroidism.
2. Rest for 1 week to prevent complications of the medication.
3. Take thyroxine replacement for the remainder of the client's life.
4. Assess for hypertension and tachycardia resulting from altered thyroid activity.
3. Take thyroxine replacement for the remainder of the client's life.
The client needs to be educated about the need for lifelong thyroid hormone
replacement. Permanent hypothyroidism is the major complication of RAI 131I
treatment. Lifelong medical follow-up and thyroid replacement are warranted.
The client needs to
monitor for signs and symptoms of hypothyroidism, not hyperthyroidism. Resting
for 1 week is not necessary. Hypertension and tachycardia are signs of
hyperthyroidism, not hypothyroidism.
CN: Pharmacological and parenteral therapies; CL: Synthesize
The nurse is completing a health assessment of a 42-year-old female with
suspected Graves' Disease. The nurse should assess this client for:
1. anorexia
3|Page
, Med-Surg II HESI Exam
2. tachycardia
3. weight gain
4. cold skin
2. tachycardia
Graves' disease, the most common type of thyrotoxicosis, is a state of
hypermetabolism. The increased metabolic rate generates heat and produces
tachycardia and fine muscle tremors. Anorexia is associated with hypothyroidism.
Loss of weight, despite a good appetite and adequate caloric intake, is a common
feature of hyperthyroidism. Cold skin is associated with hypothyroidism.
CN: Physiological adaptation; CL: Analyze
When conducting a health history with a female client with thyrotoxicosis, the
nurse should ask about which of the following changes in the menstrual cycle?
1. dysmenorrhea
2. metrorrhagia
3. oligomenorrhea
4. menorrhagia
3. oligomenorrhea
A change in the menstrual interval, diminished menstrual flow (oligomenorrhea),
or even the absence of menstruation (amenorrhea) may result from the hormonal
imbalances of thyrotoxicosis. Oligomenorrhea in women and decreased libido and
impotence in men are common features of thyrotoxicosis. Dysmenorrhea is
painful menstruation. Metrorrhagia, blood loss between menstrual periods, is a
symptom of hypothyroidism. Menorrhagia, excessive bleeding during menstrual
periods, is a symptom of hypothyroidism.
CN: Physiological adaptation; CL: Analyze
4|Page